Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CEFEPIME vs CEFOPERAZONE\SULBACTAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CEFEPIME vs CEFOPERAZONE\SULBACTAM: Safety Overview

Metric CEFEPIME CEFOPERAZONE\SULBACTAM
Total FAERS Reports 5,540 797
Deaths Reported 997 131
Death Rate 18.0% 16.4%
Hospitalizations 3,055 367
Average Patient Age 56.5 yrs 57.9 yrs
% Female Patients 47.6% 30.6%
FDA Approval Date Aug 21, 2018 N/A
Manufacturer Apotex Corp. N/A
Route INTRAMUSCULAR N/A
Marketing Status Discontinued N/A